DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
Global Peripheral Vascular Devices Market Poised for Robust Growth at a CAGR of 6% Through 2032 as Demand for Minimally Invasive Treatments Surges | DelveInsight The global peripheral vascular devices ...
Drug-coated stents and balloons were not associated with a reduction in amputations or improved quality of life compared with uncoated devices among patients with peripheral artery disease, according ...
The US Food and Drug Administration (FDA) issued draft guidance Thursday to aid sponsors in developing 510(k) submissions for peripheral vascular atherectomy devices. The 31-page document provides ...
The U.S. FDA has finalized a guidance for class II devices for treatment of peripheral artery disease that excludes drug-coated balloons (DCBs), which are regulated as class III devices. One of the ...
ROHM has developed a wireless power supply IC chipset consisting of the receiver — ML7670 — and transmitter — ML7671 — ...
With the increasing application of IT installations in maritime environments, the requirements for optimized operation increase as well. KVM technology said it offers versatile ways to contribute to ...
Smart meters are key parts of the smart-grid power-distribution networks now being rolled out internationally to achieve economic and environmental benefits. Traditional energy meters are mechanical, ...
Madrid, Spain – 31 August 2025: Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results